TuisCZMWY • OTCMKTS
add
Carl Zeiss Meditec ADR
Vorige sluiting
$57,54
Dagwisseling
$57,52 - $58,60
Jaarwisseling
$57,13 - $134,60
Markkapitalisasie
4,95 mjd EUR
Gemiddelde volume
9,67 k
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(EUR) | Jun. 2024info | J/J-verandering |
---|---|---|
Inkomste | 539,34 m | 0,79% |
Bedryfskoste | 238,78 m | 11,27% |
Netto inkomste | 34,13 m | -62,96% |
Netto winsgrens | 6,33 | -63,24% |
Wins per aandeel | 0,43 | — |
EBITDA | 60,11 m | -43,58% |
Effektiewe belastingkoers | 32,31% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(EUR) | Jun. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 15,34 m | 24,06% |
Totale bates | — | — |
Totale aanspreeklikheid | — | — |
Totale ekwiteit | 2,11 mjd | — |
Uitstaande aandele | 89,74 m | — |
Prys om te bespreek | 2,46 | — |
Opbrengs op bates | — | — |
Opbrengs op kapitaal | 6,08% | — |
Kontantvloei
Netto kontantverandering
(EUR) | Jun. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 34,13 m | -62,96% |
Kontant van bedrywe | — | — |
Kontant van beleggings | — | — |
Kontant van finansiering | — | — |
Netto kontantverandering | — | — |
Beskikbare kontantvloei | — | — |
Meer oor
Carl Zeiss Meditec AG is a multinational medical technology company and subsidiary of Carl Zeiss AG. It manufactures tools for eye examinations and medical lasers as well as solutions for neurosurgery, dentistry, gynecology and oncology. Among its products are the most common tools used by ophthalmologists and optometrists.
In October 2018, Carl Zeiss Meditec won FDA premarket approval for its ReLEx Smile laser system.
Also in October 2018, Carl Zeiss Meditec announced the acquisition of Reno, Nevada-based IanTech for an undisclosed sum.
In September 2019, Carl Zeiss Meditec launched the CIRRUS 6000 at the European Society of Retina Specialists 2019 Congress. Wikipedia
HUB
Gestig
2002
Hoofkwartier
Werknemers
4 950